日本心脏移植候选者的存活率。
Survival of Heart Transplant Candidates in Japan.
机构信息
Department of Therapeutic Strategy for Severe Heart Failure, Graduate School of Medicine, Tokyo Women's Medical University.
Department of Cardiovascular Medicine, Tokyo Medical and Dental University.
出版信息
Circ J. 2019 Feb 25;83(3):681-683. doi: 10.1253/circj.CJ-17-0024. Epub 2018 Dec 27.
BACKGROUND
In Japan, there are more patients waiting for heart transplants (HTXs) than available organs.
METHODS AND RESULTS
Since July 2010, 68 pediatric and 366 adult patients aged <60 years applied for HTX candidacy with the Japanese Circulation Society's HTX Committee. No significant differences in freedom from death or HTX were observed between pediatric Status 1 and Status 2 patients. More adult Status 1 patients reached the endpoint of death or HTX than adult Status 2 patients. Pediatric patients (Status 1 and 2) did not have better survival than adult Status 1 or Status 2 patients.
CONCLUSIONS
Pediatric patients should be prioritized over adult patients for HTX.
背景
在日本，等待心脏移植（HTX）的患者比可供移植的器官多。
方法和结果
自 2010 年 7 月以来，68 名儿科患者和 366 名年龄<60 岁的成年患者向日本循环学会 HTX 委员会申请 HTX 候选资格。在无死亡或 HTX 方面，儿科 1 级和 2 级患者之间没有显著差异。与成人 2 级患者相比，更多的成人 1 级患者达到死亡或 HTX 的终点。儿科患者（1 级和 2 级）的存活率并不优于成人 1 级或 2 级患者。
结论
儿科患者应优先接受 HTX 治疗，而不是成年患者。
Zotero 插件